Peter P. Liu

29.9k total citations · 10 hit papers
197 papers, 18.6k citations indexed

About

Peter P. Liu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Peter P. Liu has authored 197 papers receiving a total of 18.6k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Cardiology and Cardiovascular Medicine, 49 papers in Molecular Biology and 29 papers in Surgery. Recurrent topics in Peter P. Liu's work include Heart Failure Treatment and Management (35 papers), Cardiovascular Function and Risk Factors (33 papers) and Cardiac Fibrosis and Remodeling (25 papers). Peter P. Liu is often cited by papers focused on Heart Failure Treatment and Management (35 papers), Cardiovascular Function and Risk Factors (33 papers) and Cardiac Fibrosis and Remodeling (25 papers). Peter P. Liu collaborates with scholars based in Canada, United States and China. Peter P. Liu's co-authors include Jack V. Tu, Douglas S. Lee, Peter C. Austin, Yanyan Gong, Jean L. Rouleau, Hongliang Li, Fayez Dawood, Douglas L. Mann, R. Sacha Bhatia and Annick Haouzi and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Peter P. Liu

194 papers receiving 18.1k citations

Hit Papers

Outcome of Heart Failure with Preserved Ejection Fract... 1994 2026 2004 2015 2006 2003 1994 2020 2011 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
    2006 1.5k citations Jack V. Tu, Douglas S. Lee et al. New England Journal of Medicine profile →
  2. Predicting Mortality Among Patients Hospitalized for Heart Failure
    2003 1.0k citations Douglas S. Lee, Peter C. Austin et al. profile →
  3. Survival in Medically Treated Patients with Homozygous β-Thalassemia
    1994 702 citations Nancy F. Olivieri, Peter P. Liu et al. New England Journal of Medicine profile →
  4. The Science Underlying COVID-19
    2020 562 citations Peter P. Liu, Alice Blet et al. Circulation profile →
  5. Myocarditis
    2011 512 citations Peter P. Liu, Leslie T. Cooper et al. profile →
  6. Role of innate and adaptive immune mechanisms in cardiac injury and repair
    2015 476 citations Peter P. Liu et al. profile →
  7. Dilated cardiomyopathy
    2019 411 citations Peter P. Liu et al. profile →
  8. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association
    2017 404 citations Sheryl L. Chow, Alan S. Maisel et al. Circulation profile →
  9. Targeting metabolic dysregulation for fibrosis therapy
    2019 348 citations Xiao Zhao, Jennifer Kwan et al. Nature Reviews Drug Discovery profile →
  10. Applications of 3D printing in cardiovascular diseases
    2016 294 citations Peter P. Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter P. Liu Canada 68 9.6k 3.5k 2.7k 2.5k 2.5k 197 18.6k
Douglas E. Vaughan United States 70 6.5k 0.7× 4.0k 1.1× 2.9k 1.1× 2.0k 0.8× 1.8k 0.7× 229 17.0k
Antoni Bayés‐Genís Spain 65 12.9k 1.3× 3.4k 0.9× 4.3k 1.6× 1.4k 0.6× 2.2k 0.9× 815 20.6k
David A. Roth United States 47 4.1k 0.4× 2.3k 0.7× 3.0k 1.1× 2.0k 0.8× 2.9k 1.2× 212 20.6k
Seiichi Matsuo Japan 60 3.2k 0.3× 3.1k 0.9× 2.9k 1.1× 1.9k 0.8× 2.7k 1.1× 321 17.7k
Myron A. Waclawiw United States 56 4.1k 0.4× 3.1k 0.9× 2.0k 0.8× 1.3k 0.5× 1.4k 0.6× 139 14.9k
Ton J. Rabelink Netherlands 81 6.9k 0.7× 7.1k 2.0× 4.9k 1.8× 1.9k 0.8× 3.2k 1.3× 542 25.9k
Maria Benedetta Donati Italy 68 3.0k 0.3× 2.8k 0.8× 2.2k 0.8× 1.9k 0.7× 1.8k 0.7× 573 17.3k
Frank W. Sellke United States 65 7.1k 0.7× 5.8k 1.6× 5.9k 2.2× 1.3k 0.5× 2.2k 0.9× 575 22.7k
Claudio Napoli Italy 70 4.5k 0.5× 6.2k 1.8× 3.6k 1.4× 1.5k 0.6× 2.0k 0.8× 450 20.5k
Arshed A. Quyyumi United States 86 14.8k 1.5× 5.0k 1.4× 5.5k 2.1× 2.1k 0.8× 2.7k 1.1× 484 29.7k

Countries citing papers authored by Peter P. Liu

Since Specialization
Citations

This map shows the geographic impact of Peter P. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter P. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter P. Liu more than expected).

Fields of papers citing papers by Peter P. Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter P. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter P. Liu. The network helps show where Peter P. Liu may publish in the future.

Co-authorship network of co-authors of Peter P. Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Peter P. Liu. A scholar is included among the top collaborators of Peter P. Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter P. Liu. Peter P. Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McNamara, Dennis M., Leslie T. Cooper, Arvind Bhimaraj, et al.. (2024). Impact of Cannabidiol on Myocardial Recovery in Patients with Acute Myocarditis: Rationale & Design of the ARCHER Trial. ESC Heart Failure. 11(5). 3416–3424. 5 indexed citations
2.
Cheng, Alice, et al.. (2024). The Continuing Scourge of Atherosclerotic Cardiovascular Disease: Importance of Multidisciplinary and Innovative Person-Centred Approaches. Canadian Journal of Cardiology. 40(8). S43–S52. 1 indexed citations
3.
Bouchard, Karen, Peter P. Liu, Kerstin Dautenhahn, et al.. (2023). Cardiology professionals’ views of social robots in augmenting heart failure patient care. European Heart Journal - Digital Health. 5(1). 69–76. 1 indexed citations
4.
Sun, Louise Y., Salwa S. Zghebi, Anan Bader Eddeen, et al.. (2022). Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients With Incident Diabetes. Diabetes Care. 45(11). 2737–2745. 2 indexed citations
5.
Smyth, David, Alice Blet, Qiujiang Du, et al.. (2022). Insulin-like growth factor-binding protein-7 (IGFBP7) links senescence to heart failure. Nature Cardiovascular Research. 1(12). 1195–1214. 29 indexed citations
6.
Chu, Joseph, Gordon W. Moe, Manav V. Vyas, et al.. (2022). Epidemiology of COVID-19 and Its Cardiac and Neurologic Complications Among Chinese and South Asians in Ontario: Waves 1, 2, and 3. CJC Open. 4(10). 894–904.
7.
Yu, Chia‐Jung, Chih‐Hsing Wu, Ming‐Jer Tang, et al.. (2021). The Pathophysiologic Role of Gelsolin in Chronic Kidney Disease: Focus on Podocytes. International Journal of Molecular Sciences. 22(24). 13281–13281. 2 indexed citations
8.
Chu, Joseph, Maria Koh, Robert Chen, et al.. (2021). COVID-19 and its Cardiac and Neurological Complications among Ontario Visible Minorities. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 49(4). 504–513. 5 indexed citations
9.
Bayés‐Genís, Antoni, Peter P. Liu, David E. Lanfear, et al.. (2020). Omics phenotyping in heart failure: the next frontier. European Heart Journal. 41(36). 3477–3484. 44 indexed citations
10.
Sun, Louise Y., Lisa Mielniczuk, Peter P. Liu, et al.. (2020). Sex-specific temporal trends in ambulatory heart failure incidence, mortality and hospitalisation in Ontario, Canada from 1994 to 2013: a population-based cohort study. BMJ Open. 10(11). e044126–e044126. 2 indexed citations
11.
Zhao, Xiao, Jennifer Kwan, Kenneth W. Yip, Peter P. Liu, & Fei‐Fei Liu. (2019). Targeting metabolic dysregulation for fibrosis therapy. Nature Reviews Drug Discovery. 19(1). 57–75. 348 indexed citations breakdown →
12.
Chow, Sheryl L., Alan S. Maisel, Inder S. Anand, et al.. (2017). Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 135(22). e1054–e1091. 404 indexed citations breakdown →
13.
Martino, Tami A., Nazneen Tata, Jeremy A. Simpson, et al.. (2011). The Primary Benefits of Angiotensin-Converting Enzyme Inhibition on Cardiac Remodeling Occur During Sleep Time in Murine Pressure Overload Hypertrophy. Journal of the American College of Cardiology. 57(20). 2020–2028. 76 indexed citations
14.
Sun, Mei, Manyin Chen, Youan Liu, et al.. (2010). Cathepsin-L contributes to cardiac repair and remodelling post-infarction. Cardiovascular Research. 89(2). 374–383. 54 indexed citations
15.
Koskivirta, Ilpo, Zamaneh Kassiri, Otto Rahkonen, et al.. (2010). Mice with Tissue Inhibitor of Metalloproteinases 4 (Timp4) Deletion Succumb to Induced Myocardial Infarction but Not to Cardiac Pressure Overload. Journal of Biological Chemistry. 285(32). 24487–24493. 79 indexed citations
16.
Yan, Andrew T., Raymond T. Yan, Francis G. Spinale, et al.. (2008). Relationships Between Plasma Levels of Matrix Metalloproteinases and Neurohormonal Profile in Patients with Heart Failure. European Journal of Heart Failure. 10(2). 125–128. 28 indexed citations
17.
Lee, Douglas S., Peter P. Liu, Paul Dorian, et al.. (2003). Effectiveness of implantable defibrillators for preventing arrhythmic events and death. Journal of the American College of Cardiology. 41(9). 1573–1582. 132 indexed citations
18.
Opavsky, Mary Anne, Tami A. Martino, Marlene Rabinovitch, et al.. (2002). Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. Journal of Clinical Investigation. 109(12). 1561–1569. 89 indexed citations
19.
Opavsky, Mary Anne, Tami A. Martino, Marlene Rabinovitch, et al.. (2002). Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. Journal of Clinical Investigation. 109(12). 1561–1569. 5 indexed citations
20.
Olivieri, Nancy F., Peter P. Liu, Graham D. Sher, et al.. (1994). Combined Liver and Heart Transplantation for End-Stage Iron-Induced Organ Failure in an Adult with Homozygous Beta-Thalassemia. New England Journal of Medicine. 330(16). 1125–1127. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas E. Vaughan Breakdown of academic impact, for papers by Antoni Bayés‐Genís Breakdown of academic impact, for papers by David A. Roth Breakdown of academic impact, for papers by Seiichi Matsuo Breakdown of academic impact, for papers by Myron A. Waclawiw Breakdown of academic impact, for papers by Ton J. Rabelink Breakdown of academic impact, for papers by Maria Benedetta Donati Breakdown of academic impact, for papers by Frank W. Sellke Breakdown of academic impact, for papers by Claudio Napoli Breakdown of academic impact, for papers by Arshed A. Quyyumi
Rankless by CCL
2026